Elevated PTPN2 expression is associated with inferior molecular response in de-novo chronic myeloid leukaemia patients.

Kok, C H; Leclercq, T; Watkins, D B; Saunders, V; Wang, J; Hughes, T P; White, D L

Kok, C H; Leclercq, T; Watkins, D B; Saunders, V; Wang, J; Hughes, T P; White, D L.

Afiliação

Kok CH; 1] Cancer Theme, South Australia Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia [2] Department of Medicine, Centre for Personalized Cancer Medicine, University of Adelaide, Adelaide, SA, Australia.
Leclercq T; Cancer Theme, South Australia Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Watkins DB; 1] Cancer Theme, South Australia Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia [2] Department of Medicine, Centre for Personalized Cancer Medicine, University of Adelaide, Adelaide, SA, Australia.
Saunders V; Cancer Theme, South Australia Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Wang J; 1] Cancer Theme, South Australia Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia [2] Department of Medicine, Centre for Personalized Cancer Medicine, University of Adelaide, Adelaide, SA, Australia.
Hughes TP; 1] Cancer Theme, South Australia Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia [2] Department of Medicine, Centre for Personalized Cancer Medicine, University of Adelaide, Adelaide, SA, Australia [3] Department of Haematology, SA Pathology, Adelaide, SA, Australia [4] Centr
White DL; 1] Cancer Theme, South Australia Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia [2] Department of Medicine, Centre for Personalized Cancer Medicine, University of Adelaide, Adelaide, SA, Australia [3] Centre for Cancer Biology, Adelaide, SA, Australia.

Leukemia ; 28(3): 702-5, 2014 Mar.

Article em En | MEDLINE | ID: mdl-24192813

Assuntos

Leucemia Mielogênica Crônica BCR-ABL Positiva/metabolismo; Proteína Tirosina Fosfatase não Receptora Tipo 2/metabolismo; Estudos de Coortes; Humanos; Leucemia Mielogênica Crônica BCR-ABL Positiva/patologia; Proteína Tirosina Fosfatase não Receptora Tipo 2/genética; RNA Mensageiro/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteína Tirosina Fosfatase não Receptora Tipo 2 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google